Details

Last Funding Type

Post-IPO Debt

Last Funding Money Raised

€35M

Industries

Clinical Trials,Health Care,Pharmaceutical

Founded date

Jan 1, 2002

Number Of Employee

101 - 250

Operating Status

Active

MEDIAN Technologies develops medical imaging software and services dedicated to oncology clinical trials, cancer screening, and clinical practice. The company standardizes and automates the interpretation of medical images in oncology to optimize the diagnosis of cancer patients and the assessment of their response to therapy. The company serves two primary markets: drug development and patient care.

MEDIAN Technologies has a strategic partnership with a contract research organization to offer integrated imaging services for clinical trials to biopharma sponsors worldwide, and a strategic partnership with Canon to develop new imaging technologies, and to address the patient care market.

MEDIAN Technologies was founded in 2002 and is based in Sophia-Antipolis, France.